NovaQuest Pharma Opportunities Fund III is a Private Equity Fund in North Carolina, that has raised $426.10 mm (out of $500.00 mm offered) from 8 investors, for a fund started in Nov 2010. Data from SEC filing on 13 Nov 2012.
Company profile
Employees
Incorporated
Location
Fiscal year end
Industry
Former names
NovaQuest Healthcare Investment Fund III, L.P., NovaQuest Healthcare Investment Fund, L.P.
SEC CIK
IRS number
800647974
AUM ?
$57.64 mm
Address
NovaQuest Pharma Opportunities Fund III
4208 SIX FORKS ROAD
SUITE 920
RALEIGH
NC 27609
4208 SIX FORKS ROAD
SUITE 920
RALEIGH
NC 27609
Phone
919-459-8620
Ownership
Fund structure | AUM | Fund type |
---|---|---|
Novaquest Capital Management, L.L.C. | $1.79 bn | |
Novaquest Animal Health Opportunities Fund (Delaware), L.P. | $80.63 mm | Private Equity Fund |
Novaquest Animal Health Opportunities Fund Aggregator, L.P. | $89.82 mm | Private Equity Fund |
Novaquest Animal Health Opportunities Fund, L.P. | $5.95 mm | Private Equity Fund |
Novaquest Co-investment - Risp, L.P. | $26.88 mm | Private Equity Fund |
Novaquest Co-investment - Tak, L.P. | $3.00 mm | Private Equity Fund |
Novaquest Co-investment Fund I (Parent), L.P. | $565.00 k | Private Equity Fund |
Novaquest Co-investment Fund III, L.P. | $32.50 mm | Private Equity Fund |
Novaquest Co-investment Fund IX, L.P. | $60.17 mm | Private Equity Fund |
Novaquest Co-investment Fund VI, L.P. | $25.92 mm | Private Equity Fund |
Novaquest Co-investment Fund VII, L.P. | $39.39 mm | Private Equity Fund |
Novaquest Co-investment Fund VIII, L.P. | $241.63 mm | Private Equity Fund |
Novaquest Co-investment Fund XI, L.P. | $25.47 mm | Private Equity Fund |
Novaquest Co-investment Fund XIII, L.P. | $24.99 mm | Private Equity Fund |
Novaquest Co-investment Fund XV, L.P. | $38.71 mm | Private Equity Fund |
Novaquest Co-investment Fund XVI, L.P. | $74.23 mm | Private Equity Fund |
Novaquest Co-investment Fund XVII, L.P. | $50.18 mm | Private Equity Fund |
Novaquest Co-investment Fund XVIII, L.P. | $36.62 mm | Private Equity Fund |
Novaquest Fund III Aiv I, L.P. | $357.00 k | Private Equity Fund |
Novaquest Pharma Opportunities Fund III Aggregator, L.P. | $36.35 mm | Private Equity Fund |
Novaquest Pharma Opportunities Fund III, L.P. | $57.64 mm | Private Equity Fund |
Novaquest Pharma Opportunities Fund IV (Co-invest-a), L.P. | $8.67 mm | Private Equity Fund |
Novaquest Pharma Opportunities Fund IV (Co-invest-a), L.P. | $27.87 mm | Private Equity Fund |
Novaquest Pharma Opportunities Fund IV (Co-invest), L.P. | $73.69 mm | Private Equity Fund |
Novaquest Pharma Opportunities Fund IV (Parallel), L.P. | $31.07 mm | Private Equity Fund |
Novaquest Pharma Opportunities Fund IV Aggregator, L.P. | $152.22 mm | Private Equity Fund |
Novaquest Pharma Opportunities Fund IV, L.P. | $230.24 mm | Private Equity Fund |
Novaquest Pharma Opportunities Fund V (Delaware), L.P. | $396.66 mm | Private Equity Fund |
Novaquest Pharma Opportunities Fund V (Delaware) Feeder, L.P. | ||
Novaquest Pharma Opportunities Fund V, L.P. | $679.44 mm | Private Equity Fund |
NQ Ah Project Arlington II, L.P. | $13.40 mm | Private Equity Fund |
NQ Cove Aggregator, L.P. | $18.80 mm | Private Equity Fund |
NQ Project Bridgeton, L.P. | $73.35 mm | Private Equity Fund |
NQ Project Glasgow, LTD. | $75.58 mm | Private Equity Fund |
NQ Project Pharaoh, L.P. | $129.41 mm | Private Equity Fund |
NQ Project Phoebus, L.P. | $51.06 mm | Private Equity Fund |
NQ Project Sampson, L.P. | $35.52 mm | Private Equity Fund |
NQP Aiv I, L.P. | $105.40 mm | Private Equity Fund |
NQP SPV I, L.P. | $184.57 mm | Private Equity Fund |
NQP SPV II, L.P. | $86.57 mm | Private Equity Fund |
Latest ownership filings
13F-NT
Notice of holdings reported by another manager
25 Oct 19
13F-NT
Notice of holdings reported by another manager
29 Jul 19
13F-NT
Notice of holdings reported by another manager
8 May 19
13F-NT
Notice of holdings reported by another manager
12 Feb 19
SC 13G/A
Revance Therapeutics, Inc.
12 Feb 19
13F-NT
Notice of holdings reported by another manager
7 Nov 18
13F-NT
Notice of holdings reported by another manager
2 Aug 18
13F-NT
Notice of holdings reported by another manager
24 Apr 18
13F-NT
Notice of holdings reported by another manager
13 Feb 18
SC 13G/A
Revance Therapeutics, Inc.
8 Feb 17